FDA Inspection 1081616 — Vitalant
The FDA completed an inspection of Vitalant on Feb 22, 2019 in Aberdeen, SD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 22, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Aberdeen, SD (United States)